Page 4 - Ioscience News Today

Anthem Biosciences partners with Veeva to accelerate availability of new medicines

Regencell Bioscience Holdings Limited Announces First Half 2023 Management Financial Results HONG KONG, June 15, 2023 - Regencell Bioscience Holdings Limited , today announced... | June 15, 2023

TUCSON, (KVOA) - The University of Arizona will be the home of a new top of the line MRI.

KELOWNA, BC / ACCESSWIRE / June 12, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of

Dr. Alan K. Jacobs joins Satellos as CMO on June 7th, 2023 Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine

Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell

Skye plans to complete enrollment of Phase 1 study in June San Diego, California--(Newsfile Corp. - June 2, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company

TORONTO — TORONTO — Satellos Bioscience Inc. on Tuesday reported a loss of $1.2 million in its first quarter. On a per-share basis, the Toronto-based company said it had a loss of... | May 30, 2023

- $55 million equity financing closed- Resourced to advance lead drug candidate into clinical trialsToronto, Ontario--(Newsfile Corp. - May 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos"

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D.,... | May 24, 2023